These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9724905

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Irvingia gabonensis (O'Rorke) Bail polymer matrix system for controlled drug delivery.
    Patani BO, Akin-Ajani OD, Kumaran A, Odeku OA.
    Polim Med; 2022; 52(2):67-76. PubMed ID: 36268745
    [Abstract] [Full Text] [Related]

  • 24. Desktop 3D printing of controlled release pharmaceutical bilayer tablets.
    Khaled SA, Burley JC, Alexander MR, Roberts CJ.
    Int J Pharm; 2014 Jan 30; 461(1-2):105-11. PubMed ID: 24280018
    [Abstract] [Full Text] [Related]

  • 25. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
    Zhang F, Meng F, Wang ZY, Na W.
    Drug Dev Ind Pharm; 2017 Feb 30; 43(2):190-203. PubMed ID: 27599027
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
    Salunkhe KS, Kulkarni MV.
    Pak J Pharm Sci; 2008 Jan 30; 21(1):17-20. PubMed ID: 18166513
    [Abstract] [Full Text] [Related]

  • 28. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
    Shah S, Shah K, Jan SU, Ahmad K, Rehman A, Hussain A, Khan GM.
    Pak J Pharm Sci; 2011 Jul 30; 24(3):255-61. PubMed ID: 21715257
    [Abstract] [Full Text] [Related]

  • 29. Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination.
    Khan KA, Khan GM, Shah KU, Niazi ZR, Khan H, Ahmad A, -Ur-Rehman F, Shah PA, Ullah A, Tahir M, Jan SU.
    Pak J Pharm Sci; 2020 Sep 30; 33(5(Supplementary)):2231-2237. PubMed ID: 33832895
    [Abstract] [Full Text] [Related]

  • 30. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
    Riis T, Bauer-Brandl A, Wagner T, Kranz H.
    Eur J Pharm Biopharm; 2007 Jan 30; 65(1):78-84. PubMed ID: 16919924
    [Abstract] [Full Text] [Related]

  • 31. In vitro evaluation of gentamicin- and vancomycin-containing minitablets as a replacement for fortified eye drops.
    Bozdag S, Weyenberg W, Adriaens E, Dhondt MM, Vergote V, Vervaet C, De Prijck K, Nelis HJ, De Spiegeleer B, Ludwig A, Remon JP.
    Drug Dev Ind Pharm; 2010 Nov 30; 36(11):1259-70. PubMed ID: 20545514
    [Abstract] [Full Text] [Related]

  • 32. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, Zimny E.
    AAPS PharmSciTech; 2016 Feb 30; 17(1):214-32. PubMed ID: 26757898
    [Abstract] [Full Text] [Related]

  • 33. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A, Bergamante V, Ceschel GC, Ronchi C, de Moraes CA.
    Eur J Pharm Biopharm; 2008 May 30; 69(1):335-41. PubMed ID: 18182280
    [Abstract] [Full Text] [Related]

  • 34. Oral sustained-release bioadhesive tablet formulation of didanosine.
    Betageri GV, Deshmukh DV, Gupta RB.
    Drug Dev Ind Pharm; 2001 Feb 30; 27(2):129-36. PubMed ID: 11266224
    [Abstract] [Full Text] [Related]

  • 35. Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging.
    Pudlas M, Kyeremateng SO, Williams LAM, Kimber JA, van Lishaut H, Kazarian SG, Woehrle GH.
    Eur J Pharm Sci; 2015 Jan 25; 67():21-31. PubMed ID: 25445833
    [Abstract] [Full Text] [Related]

  • 36. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM, Sankalia MG, Mashru RC.
    J Control Release; 2008 Jul 02; 129(1):49-58. PubMed ID: 18456362
    [Abstract] [Full Text] [Related]

  • 37. Application of Aquasolv Lignin in ibuprofen-loaded pharmaceutical formulations obtained via direct compression and wet granulation.
    Gil-Chávez J, Padhi SSP, Leopold CS, Smirnova I.
    Int J Biol Macromol; 2021 Mar 31; 174():229-239. PubMed ID: 33454332
    [Abstract] [Full Text] [Related]

  • 38. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY, Yang YP, Chang JB, Guo MT.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct 18; 44(5):742-8. PubMed ID: 23073585
    [Abstract] [Full Text] [Related]

  • 39. Quantifying the release of lactose from polymer matrix tablets with an amperometric biosensor utilizing cellobiose dehydrogenase.
    Knöös P, Schulz C, Piculell L, Ludwig R, Gorton L, Wahlgren M.
    Int J Pharm; 2014 Jul 01; 468(1-2):121-32. PubMed ID: 24726632
    [Abstract] [Full Text] [Related]

  • 40. The use of response surface methodology for the formulation and optimization of salbutamol sulfate hydrophilic matrix sustained release tablets.
    Chaibva FA, Walker RB.
    Pharm Dev Technol; 2012 Jul 01; 17(5):594-606. PubMed ID: 21428702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.